Toggle navigation
Home
Search
Services
Blog
Contact
About
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W.
Covance Laboratories, Inc., Vienna, VA, United States
Search 19 grants from Daniel Dalgard
Search grants from Covance Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Florida
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of the Tie2-Angpt axis in the regulation of endothelial cell immunogenicity
Regulation of Ion Cotransport Proteins
Monoclonal Antibodies to Prostate Tumor Antigens
Cardiac Arrhythmia Suppression Trial
5HT3 Antagonist, Gr-C 507/75, on Small Bowel Transit
Recently added grants:
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection
Microbiota Specific T Cell Selection
Lipid Antigens for iNKT Cells in the Gut Microenvironment
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
Human B1-like Cells and Pneumococcal Defense in the Elderly
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM025601-009
Application #
3609868
Study Section
Project Start
1981-11-01
Project End
1984-10-31
Budget Start
1985-02-20
Budget End
1984-10-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Covance Laboratories, Inc.
Department
Type
DUNS #
City
Vienna
State
VA
Country
United States
Zip Code
22182
Related projects
NIH 1986
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
NIH 1985
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
Comments
Be the first to comment on Daniel Dalgard's grant